NEWARK, DE, USA – The global artificial tears market is projected to expand from USD 3.9 billion in 2026 to USD 6.5 billion by 2036, registering a compound annual growth rate (CAGR) of 5.2% during the forecast period, according to Future Market Insights (FMI). Increasing cases of dry eye disease, rising digital screen exposure, aging populations, and growing awareness of eye health are supporting demand for artificial tears and ocular lubricants.

Artificial tears are used to relieve eye dryness, irritation, and discomfort by supplementing the natural tear film. Their use across routine eye care and dry eye management is creating opportunities for pharmaceutical companies and ophthalmic product manufacturers. Growing consumer interest in convenient over-the-counter products, alongside demand for advanced formulations, is also contributing to market development.

Request For a Report Sample: https://www.futuremarketinsights.com/reports/sample/rep-gb-18329

FMI estimates that sodium hyaluronate-based artificial tears will account for 28.4% of the product type segment in 2026, while solution formulations will represent 49.7% of the dosage form segment. These categories highlight the importance of hydration-focused formulations and easy-to-administer eye drop products.

Artificial Tears Market: Key Takeaways

·         Market size in 2026: USD 3.9 billion

·         Forecast market value by 2036: USD 6.5 billion

·         Market CAGR (2026–2036): 5.2%

·         Leading product type: Sodium hyaluronate-based artificial tears, with a 28.4% share

·         Leading dosage form: Solutions, with a 49.7% share

·         Fastest-growing profiled country: China, with a projected 10.2% CAGR

·         Key companies: Alcon, AbbVie, Akorn, Bausch + Lomb, Johnson & Johnson, Santen Pharmaceutical, and Sun Pharmaceutical Industries

Rising Dry Eye Prevalence Supports Market Expansion

The increasing prevalence of dry eye symptoms is a major factor supporting artificial tears demand. Aging populations, prolonged digital device usage, environmental pollution, air conditioning, and contact lens use can contribute to ocular dryness and irritation. As awareness of these factors increases, consumers are showing greater interest in products that support eye lubrication and comfort.

Extended screen time is particularly relevant to modern lifestyles. Reduced blinking during prolonged digital device use can contribute to tear-film instability and discomfort. Artificial tears are commonly used to provide temporary lubrication and relieve symptoms associated with dry eyes.

An aging population is another important demand driver. Tear production and ocular surface function can change with age, increasing the likelihood of dry eye symptoms. This creates demand for products that can support regular eye care and symptom management.

Sodium Hyaluronate Formulations Lead Product Demand

By product type, sodium hyaluronate-based artificial tears are projected to hold 28.4% of the market in 2026. Sodium hyaluronate is valued for its water-retaining and lubricating properties. Its ability to support moisture on the ocular surface makes it an important ingredient in artificial tear formulations.

Other product categories include glycerine tears, cellulose tears, oil-based emulsion tears, polyethylene glycol-based tears, and propylene glycol-based tears. These formulations address different product requirements and approaches to ocular lubrication.

By dosage form, solutions are expected to account for 49.7% of the market in 2026. Their popularity is supported by ease of application, convenient packaging, and suitability for routine use. Other dosage forms include ointments, emulsions, gels, sprays, and suspensions.

The availability of different formulations allows manufacturers to serve consumers with varying preferences and eye-care requirements. Preservative-free products and formulations designed for longer-lasting lubrication are also contributing to product innovation.

Digital Eye Strain and Product Innovation Create New Opportunities

Growing use of smartphones, computers, and other digital devices is increasing attention to eye comfort and ocular health. Consumers experiencing dryness or irritation are seeking convenient products that can be incorporated into daily routines.

Manufacturers are responding through formulation improvements, including preservative-free single-use vials, enhanced viscosity, and tear-film-mimicking products. These developments are intended to improve comfort and support product use among people who require frequent lubrication.

Retail availability is also important. Over-the-counter artificial tears allow consumers to access basic eye lubrication products through pharmacies and other retail channels. Optometry services and healthcare professionals further support awareness and product selection.

However, persistent or severe eye symptoms may require professional assessment. Product manufacturers and distributors must communicate appropriate usage instructions and avoid implying that lubricating drops treat every underlying eye condition.

China Leads Country-Level Growth

FMI projects varying growth rates across major national markets between 2026 and 2036. China is expected to record the fastest growth among the countries profiled, with a projected CAGR of 10.2%.

·         China: Projected to grow at a CAGR of 10.2% from 2026 to 2036.

·         United States: Projected to grow at a CAGR of 6.7% from 2026 to 2036.

·         Japan: Projected to grow at a CAGR of 5.3% from 2026 to 2036.

·         Germany: Projected to grow at a CAGR of 4.9% from 2026 to 2036.

·         India: Projected to grow at a CAGR of 4.7% from 2026 to 2036.

China's growth outlook reflects increasing awareness of dry eye disease, an expanding elderly population, digital device usage, and environmental factors that can contribute to ocular discomfort.

The United States is projected to grow at 6.7%, supported by awareness of dry eye management and demand for advanced ophthalmic formulations. Japan is expected to record a 5.3% CAGR, with its aging population and widespread digital device use supporting demand.

Germany is forecast to grow at 4.9%, while India is projected to register a 4.7% CAGR. In India, rising screen exposure, urbanization, pollution, and expanding access to eye-care products are contributing to market opportunities.

Competitive Landscape: Companies Focus on Formulation and Product Differentiation

The artificial tears market includes multinational ophthalmic companies, pharmaceutical manufacturers, and specialized eye-care businesses. Competition is influenced by formulation efficacy, duration of lubrication, preservative selection, product accessibility, and brand reputation.

Key companies profiled by FMI include:

·         Alcon

·         AbbVie, Inc.

·         Akorn, Inc.

·         Bausch + Lomb

·         Johnson & Johnson

·         Eyevance Pharmaceuticals LLC

·         Ocusoft

·         I-MED PHARMA

·         Santen Pharmaceutical Co. Ltd.

·         Similasan Corporation

·         Sun Pharmaceutical Industries Ltd.

·         Ursapharm Arzneimittel GmbH

·         Novartis International AG

·         AFT Pharmaceuticals

·         Allergan plc

·         Rohto Pharmaceutical Co., Ltd.

·         VISUfarma

·         Otsuka Pharmaceutical Co., Ltd.

·         NovaMedica LLC

·         ENTOD Research Cell UK Ltd.

·         OASIS Medical, Inc.

·         Abbott Medical Optics Inc.

Companies are strengthening their portfolios through product development, formulation improvements, and broader distribution networks. Alcon, AbbVie, and Bausch + Lomb are among the established participants with ophthalmic product portfolios, while regional and specialized manufacturers address particular formulation and consumer requirements.

Preservative-free options, convenient delivery systems, and products designed for different levels of dry eye symptoms are important areas of differentiation. Manufacturers that combine product quality, accessibility, and trusted eye-care branding may be well positioned to compete.

Access Full Report: https://www.futuremarketinsights.com/reports/artificial-tears-market

Outlook: Growing Eye-Care Awareness to Support Market Development

The artificial tears market is expected to maintain steady growth through 2036 as dry eye prevalence, aging demographics, digital lifestyles, and consumer awareness support demand. Formulation innovation and wider access to over-the-counter products are expected to remain important market development factors.

Companies will also need to address product safety, appropriate labeling, and evolving consumer expectations. Preservative-free formats and advanced lubrication technologies offer opportunities to improve product differentiation across consumer and clinical channels.

With the market projected to reach USD 6.5 billion by 2036, artificial tears are expected to remain an important category within the global ophthalmic and eye-care industry.

Frequently Asked Questions

1. What is the projected size of the artificial tears market by 2036?

The global artificial tears market is expected to reach USD 6.5 billion by 2036, up from USD 3.9 billion in 2026.

2. What is the expected CAGR of the artificial tears market?

The market is projected to grow at a CAGR of 5.2% between 2026 and 2036.

3. Which product type leads the artificial tears market?

Sodium hyaluronate-based artificial tears are projected to account for 28.4% of the product type segment in 2026.

4. Which dosage form holds the largest market share?

Solution formulations are expected to represent 49.7% of the dosage form segment in 2026.

5. Which country is expected to record the fastest growth?

China is projected to register the highest growth among the profiled countries, with a 10.2% CAGR from 2026 to 2036.

Related FMI Reports:

·         https://sites.google.com/view/healthcarewellnessinsights/orthopedic-prosthetic-device-market

·         https://sites.google.com/view/healthcarewellnessinsights/neonatal-and-fetal-monitors-market_1

·         https://sites.google.com/view/healthcarewellnessinsights/antimicrobial-wound-care-dressings-market

About Future Market Insights (FMI)

Future Market Insights (FMI) is a global market intelligence and consulting firm providing comprehensive market research, competitive intelligence, and strategic business insights across industries. The firm delivers detailed forecasts, technology analysis, and data-driven recommendations that support informed decision-making for manufacturers, investors, distributors, and policymakers worldwide.

For Press & Corporate Inquiries

Rahul Singh
AVP – Marketing and Growth Strategy
Future Market Insights, Inc.
+91 8600020075

For Sales – sales@futuremarketinsights.com